160 related articles for article (PubMed ID: 8174181)
1. Lethal systemic graft-vs-host disease in neonatally tolerant, but not in F1 hybrid mice.
Vizler C; Jánossy T; Baranyi L; Végh P
Cell Immunol; 1993 Feb; 146(2):431-7. PubMed ID: 8174181
[TBL] [Abstract][Full Text] [Related]
2. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
3. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
[TBL] [Abstract][Full Text] [Related]
4. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
5. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity, hyporeactivity to T cell mitogens and lymphoproliferative disorders following neonatal induction of transplantation tolerance in mice.
Jánossy T; Baranyi L; Knulst AC; Vizler C; Benner R; Kelényi G; Végh P
Eur J Immunol; 1993 Nov; 23(11):3011-20. PubMed ID: 8223878
[TBL] [Abstract][Full Text] [Related]
7. Induction of a glucocorticoid-sensitive F1-anti-parental mechanism that affects engraftment during graft-versus-host disease.
You-Ten KE; Seemayer TA; Wisse B; Bertley FM; Lapp WS
J Immunol; 1995 Jul; 155(1):172-80. PubMed ID: 7602093
[TBL] [Abstract][Full Text] [Related]
8. Graft versus host disease in rats made tolerant for organ allografts.
Morrissey NJ; Blom D; Ryan C; Fisher T; Bronsther O; Orloff M
J Surg Res; 1997 May; 69(2):307-15. PubMed ID: 9224398
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
Drobyski WR; Majewski D; Ozker K; Hanson G
J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of neonatally induced permanent transplantation tolerance in mice: quantitative aspects.
Végh P; Jánossy T
Acta Physiol Hung; 1991; 77(3-4):319-27. PubMed ID: 1755333
[TBL] [Abstract][Full Text] [Related]
11. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
[TBL] [Abstract][Full Text] [Related]
12. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
13. The influence of the age of donors and recipients on the regional graft-versus-host reaction in mice.
Skowron-Cendrzak A; Kubera M; Bubak-Satora M; Godowicz W
Arch Immunol Ther Exp (Warsz); 1991; 39(3):185-91. PubMed ID: 1810211
[TBL] [Abstract][Full Text] [Related]
14. [Suppressors of the graft vs graft reaction in tolerance to alloantigens].
Cherniakhovskaia IIu; Prigozhina TB; Nagurskaia EV; Fontalin LN
Biull Eksp Biol Med; 1988 Jun; 105(6):697-700. PubMed ID: 2968819
[TBL] [Abstract][Full Text] [Related]
15. Sequential study of an experimental model of graft vs. host disease (GvHD) in non-immunosuppressed F1 (CBA/J x C57BL/6) mice.
Acosta A; Infante JF; Sarmiento ME; Izquierdo L; Capó V; Dueñas P; Zamanillo T; Sierra G
Arch Med Res; 1994; 25(2):155-7. PubMed ID: 7919804
[TBL] [Abstract][Full Text] [Related]
16. Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.
Nagler A; Ohana M; Alper R; Doviner V; Sherman Y; Rabbani E; Engelhardt D; Ilan Y
Bone Marrow Transplant; 2003 Aug; 32(4):363-9. PubMed ID: 12900772
[TBL] [Abstract][Full Text] [Related]
17. Spleen cells from antithymocyte serum pretreated mice do not induce GVHD but exert increased repopulating activity in irradiated semiallogeneic recipients.
Vizler C; Jánossy T; Végh P
Scand J Immunol; 1995 Mar; 41(3):313-7. PubMed ID: 7871394
[TBL] [Abstract][Full Text] [Related]
18. Comparison of neonatally and adoptively induced transplantation tolerance in mice.
Hasek M; Holán V; Chutná J
Folia Biol (Praha); 1980; 26(3):167-75. PubMed ID: 6448173
[TBL] [Abstract][Full Text] [Related]
19. Experimental model of graft vs. host disease in non-immunosuppressed F1 (CBA/J x C57BL/6) mice.
Acosta A; Sarmiento ME; Infante JF; Sierra G; Izquierdo L; Capó V; Zamanillo T
Arch Med Res; 1994; 25(2):151-4. PubMed ID: 7919803
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
Brok HP; Vossen JM; Heidt PJ
Bone Marrow Transplant; 1997 Mar; 19(6):601-6. PubMed ID: 9085739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
